» Articles » PMID: 34977364

Amyloid β Aggregation Induces Human Brain Microvascular Endothelial Cell Death with Abnormal Actin Organization

Overview
Specialty Biochemistry
Date 2022 Jan 3
PMID 34977364
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral amyloid angiopathy (CAA) is a disease in which amyloid β (Aβ) is deposited on the walls of blood vessels in the brain, making those walls brittle and causing cerebral hemorrhage. However, the mechanism underlying its onset is not well understood. The aggregation and accumulation of Aβ cause the occlusion and fragility of blood vessels due to endothelial cell damage, breakdown of the blood-brain barrier, and replacement with elements constituting the blood vessel wall. In this study, we observed the effect of Aβ on human primary brain microvascular endothelial cells (hBMECs) in real-time using quantum dot nanoprobes to elucidate the mechanism of vascular weakening by Aβ. It was observed that Aβ began to aggregate around hBMECs after the start of incubation and that the cells were covered with aggregates. Aβ aggregates firmly anchored the cells on the plate surface, and eventually suppressed cell motility and caused cell death. Furthermore, Aβ aggregation induced the organization of abnormal actin, resulting in a significant increase in intracellular actin dots over 10 μm. These results suggest that the mechanism by which Aβ forms a fragile vessel wall is as follows: Aβ aggregation around vascular endothelial cells anchors them to the substrate, induces abnormal actin organization, and leads to cell death.

Citing Articles

Vascular Development of Fetal and Postnatal Neocortex of the Pig, the European Wild Boar Sus scrofa.

Sobierajski E, Czubay K, Beemelmans C, Beemelmans C, Meschkat M, Uhlenkamp D J Comp Neurol. 2024; 532(12):e70011.

PMID: 39660539 PMC: 11632654. DOI: 10.1002/cne.70011.


Amyloid-beta metabolism in age-related neurocardiovascular diseases.

Aivalioti E, Georgiopoulos G, Tual-Chalot S, Bampatsias D, Delialis D, Sopova K Eur Heart J. 2024; 46(3):250-272.

PMID: 39527015 PMC: 11735085. DOI: 10.1093/eurheartj/ehae655.


Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer's Disease.

Tsoy A, Umbayev B, Kassenova A, Kaupbayeva B, Askarova S Int J Mol Sci. 2024; 25(20).

PMID: 39456746 PMC: 11507512. DOI: 10.3390/ijms252010964.


Effects of Amyloid Beta (Aβ) Oligomers on Blood-Brain Barrier Using a 3D Microfluidic Vasculature-on-a-Chip Model.

Uzoechi S, Collins B, Badeaux C, Li Y, Kwak S, Kim D Appl Sci (Basel). 2024; 14(9).

PMID: 39027034 PMC: 11257072. DOI: 10.3390/app14093917.


Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease.

Banerjee S, Banerjee S Methods Mol Biol. 2024; 2761:355-372.

PMID: 38427250 DOI: 10.1007/978-1-0716-3662-6_26.


References
1.
Attems J, Lintner F, Jellinger K . Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol. 2004; 107(4):283-91. DOI: 10.1007/s00401-004-0822-6. View

2.
McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C . Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005; 47(2):191-199. PMC: 1373682. DOI: 10.1016/j.neuron.2005.06.030. View

3.
Weller R, Subash M, Preston S, Mazanti I, Carare R . Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol. 2008; 18(2):253-66. PMC: 8095597. DOI: 10.1111/j.1750-3639.2008.00133.x. View

4.
Morris A, Sharp M, Albargothy N, Fernandes R, Hawkes C, Verma A . Vascular basement membranes as pathways for the passage of fluid into and out of the brain. Acta Neuropathol. 2016; 131(5):725-36. PMC: 4835509. DOI: 10.1007/s00401-016-1555-z. View

5.
Marin-Padilla M, Knopman D . Developmental aspects of the intracerebral microvasculature and perivascular spaces: insights into brain response to late-life diseases. J Neuropathol Exp Neurol. 2011; 70(12):1060-9. PMC: 3227674. DOI: 10.1097/NEN.0b013e31823ac627. View